FTC Approves Final Order Preserving Competition in the Market for Over-the-Counter Motion Sickness Drugs
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that the $750 million proposed acquisition of Insight Pharmaceuticals Corporation by...